Revista médica de Chile
The most recent articles from:
Rev Med Chil
-
Revista médica de Chile · May 2022
Clinical Trial[Use of anticoagulants in patients with atrial fibrillation undergoing transcatheter aortic valve implantation].
Transcatheter Aortic Valve Implantation (TAVI) is beneficial in patients with symptomatic severe Aortic Stenosis (AS). There is no consensus about the best anticoagulation strategy for patients with a recent TAVI and with atrial fibrillation (AF). Direct oral anticoagulants (DOACs) are effective to prevent embolic events with a significant lower incidence of bleeding. There is scarce evidence about the use of these drugs in patients undergoing TAVI. ⋯ In the absence of randomized data, interventional cardiologists prescribe DOACs at discharge to patients with AF and TAVI, without following current guidelines in most cases.